Search Results 1411-1420 of 17229 for Protozoa
Regenerative Medicine Minnesota has awarded funding to three projects aimed at strengthening Minnesota's capabilities for developing and delivering therapies ...
The study also seeks to further characterize (as possible) any other serious adverse reaction(s) in the long-term in adults with prostate cancer who received at ...
Dr. Gregory Worrell shares how technological innovation is transforming the future of epilepsy care. Latest stories. Larynx transplant ...
Dr. Adam Jacob has spent his career keeping patients safe in the operating room. As a Mayo Clinic anesthesiologist, he closely monitors every heartbeat and ...
The primary purpose of this study is to assess the sensitivity for colorectal cancer (CRC) and specificity of the mt-sDNA 2.0 test. Participation eligibility.
TIGER-2: A Phase 2, Open-label, Multicenter, Safety and Efficacy Study of Oral CO-1686 as 2nd Line EGFR-directed TKI in Patients With Mutant EGFR Non-small Cell ...
A national data registry of patients receiving fecal microbiota transplantation (FMT) or other gut-related-microbiota products designed to prospectively assess ...
RIYADH, Saudi Arabia and ROCHESTER, Minn. — Saudi German Health (SGH), a leading healthcare provider and pioneer in advancing medical excellence across the ...
Applying regenerative medicine to a common shoulder surgery could have an impact on the need for follow-up revision surgery in some patients, according to a ...
The purpose of this study is to determine the benefit to postoperative facial nerve function of using electromyography (EMG) based monitoring of facial nerve ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.